Pharmaceutical sales representatives are faced with increasingly limited access to physicians as many academic medical centers and other healthcare centers adopt conflict of interest policies restricting detailing. This is another benefit versus risk challenge for physicians who need quick access to the latest information about novel drugs.

The Benefits and Risks of Limiting Pharma Sales Rep Access to Physicians

John Mack (previously Pharmaguy) was a thought leader in pharmaceutical marketing with more than 30 years experience in the digital space, including interactive game design, computer-based learning, drug website development, ehealth ethics, and social media. He has retired from this role and is now a leader in municipal government: Newtown Township PA Supervisor

Share The Benefits and Risks of Limiting Pharma Sales Rep Access to Physicians

Sign up to save your podcasts

The Benefits and Risks of Limiting Pharma Sales Rep Access to Physicians

The Benefits and Risks of Limiting Pharma Sales Rep Access to Physicians